Milne, Ph.D., Chief Executive Officer at Astria Therapeutics. "With the ALPHA-ORBIT Phase 3 trial of navenibart, we are enabling the potential for HAE patients to break free from the gravity of ...
In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Astria Therapeutics (ATXS – Research Report), with a price target of $32.00. The company’s shares closed ...
Wedbush analyst Laura Chico maintained a Buy rating on Astria Therapeutics (ATXS – Research Report) today and set a price target of $28.00. The company’s shares closed yesterday at $6.47.
Oppenheimer boosted their price objective on shares of Astria Therapeutics from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, November 14th.
“2025 promises to be an exciting year for Astria, and we are building on the momentum from a successful 2024 with the initiation of two important clinical trials,” said Jill C. Milne, Ph.D ...
Astria Therapeutics Stock Performance ATXS stock opened at $6.23 on Thursday. Astria Therapeutics, Inc. has a one year low of $5.84 and a one year high of $16.90. The firm has a market cap of $351 ...
Maybe Speed Racer and Cloud Atlas get some mentions thanks to their vocal followers, but their spacefaring epic Jupiter Ascending is typically swept under the rug. A critical and financial ...
The Chicago Cubs finished just 83-79 in 2024 as they failed to reach the postseason for the fourth consecutive season. While their offense was just about league average, first baseman Michael ...
Life would be much easier for lots of Major League Baseball players if Aaron Judge didn't exist. Of course, there's the pitchers that have to face the slugger throughout the season. And the ...
Dezeen Showroom: Spanish outdoor brand Gandia Blasco and design studio Odosdesign have evolved their quintessentially Mediterranean Ensombra sunshade with add-on seating and side tables. The ...
No Central Florida sonic booms should occur. Rather, after ascending along a southeasterly trajectory, the rocket's first-stage booster will target landing aboard a SpaceX drone ship out at sea 8 ...